Suchergebnisse - "Nyquist, Michael D"

PubPharm (21)

1

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex

enthalten in: Cancer research | 2023

von Nyquist, M. | Coleman, I. | Lucas, J. | +8

2

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

enthalten in: The Journal of clinical investigation | 2021

von Nyquist, M. | Ang, L. | Corella, A. | +18

ErratumFor: J Clin Invest. 2021 May 17;131(10):. - PMID 33998604

3

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

enthalten in: The Journal of clinical investigation | 2021

von Nyquist, M. | Ang, L. | Corella, A. | +18

ErratumIn: J Clin Invest. 2021 Jun 15;131(12):. - PMID 34128479

4

Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress

enthalten in: Cell reports | 2020

von Nyquist, M. | Corella, A. | Coleman, I. | +14

5

Molecular determinants of response to high-dose androgen therapy in prostate cancer

enthalten in: JCI insight | 2019

von Nyquist, M. | Corella, A. | Mohamad, O. | +8

6

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage

enthalten in: The Journal of clinical investigation | 2019

von Chatterjee, P. | Schweizer, M. | Lucas, J. | +12

7

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer : Models, Mechanisms and Questions

enthalten in: Cancers | 2017

von Mohammad, O. | Nyquist, M. | Schweizer, M. | +5

8

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

enthalten in: Cancer cell | 2017

von Bluemn, E. | Coleman, I. | Lucas, J. | +24

CommentIn: Cancer Cell. 2017 Oct 9;32(4):399-401. - PMID 29017052

9

Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155

enthalten in: Molecular cancer research : MCR | 2017

von Nyquist, M. | Corella, A. | Burns, J. | +8

10

Harnessing Solute Carrier Transporters for Precision Oncology

enthalten in: Molecules (Basel, Switzerland) | 2017

von Nyquist, M. | Prasad, B. | Mostaghel, E.